Northwest Investment Counselors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $76.2K | Buy |
+978
| New | +$76.2K | 0.02% | 204 |
|
|
2024
Q2 | – | Sell |
-322
| Closed | -$21.8K | – | 174 |
|
|
2024
Q1 | $21.8K | Buy |
+322
| New | +$21.8K | 0.01% | 302 |
|
|
2023
Q4 | – | Sell |
-322
| Closed | -$21.8K | – | 168 |
|
|
2023
Q3 | $21.8K | Hold |
322
| – | – | 0.01% | 300 |
|
|
2023
Q2 | $23K | Hold |
322
| – | – | 0.01% | 306 |
|
|
2023
Q1 | $22.4K | Hold |
322
| – | – | 0.01% | 316 |
|
|
2022
Q4 | $21.8K | Hold |
322
| – | – | 0.01% | 323 |
|
|
2022
Q3 | $18K | Sell |
322
-95
| -23% | -$5.31K | 0.01% | 310 |
|
|
2022
Q2 | $28K | Hold |
417
| – | – | 0.01% | 273 |
|
|
2022
Q1 | $28K | Buy |
417
+95
| +30% | +$6.38K | 0.01% | 285 |
|
|
2021
Q4 | $19K | Buy |
+322
| New | +$19K | ﹤0.01% | 310 |
|
|
2021
Q2 | – | Sell |
-322
| Closed | -$16K | – | 170 |
|
|
2021
Q1 | $16K | Buy |
+322
| New | +$16K | ﹤0.01% | 321 |
|
|
2020
Q4 | – | Sell |
-322
| Closed | -$18K | – | 166 |
|
|
2020
Q3 | $18K | Buy |
+322
| New | +$18K | 0.01% | 277 |
|
|
2019
Q4 | – | Sell |
-322
| Closed | -$14K | – | 172 |
|
|
2019
Q3 | $14K | Buy |
+322
| New | +$14K | 0.01% | 319 |
|